TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.

Slides:



Advertisements
Similar presentations
Diagnosing Tuberculosis Pamela Hepple Medecins Sans Frontieres UK.
Advertisements

TB/HIV Research Priorities: TB Preventive Therapy.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
World Health Organization TB Case Definitions
1 Identifying Cases of MDR-TB Session 3. USAID TB CARE II PROJECT Old WHO recommendations RegimenIndications 4HREZ/2HR (Category I) New cases 2SHREZ/1HREZ/5HRE.
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Diagnosis of TB.
Tuberculosis in the UK 2013 report
Tuberculosis in the UK 2014 report
The Global Plan to Stop TB, (1)
Figure 1. Number of Tuberculosis Cases: California, California Department of Public Health, Tuberculosis Control Branch Number of Tuberculosis.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
The Changing Landscape of TB: Maryland TB in 2013 Presented by Dr. David Blythe Lisa Paulos, RN MPH, Epidemiologist Center for TB Control & Prevention.
1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.
NOTIFIED TUBERCULOSIS CASES IN LITHUANIA New cases and relapses (abs.n.)
Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Tuberculosis in England 2015 report (presenting data to end of 2014) Tables and figures slide set.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Progress of the Singapore TB Elimination Programme (STEP)
2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Number of Tuberculosis Cases: California, Number of Tuberculosis Cases.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Figure 1. Number of Tuberculosis Cases: California, Number of Tuberculosis Cases
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
The Strategic Health Authority for London London and TB 4 October 2007 Lynn Altass NHSL Public Health – TB North Central London TB Network Manager.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Tuberculosis in the United States
IMPAACT 2001 STUDY Mhembere T.P. (B. Pharm (Hons), MPH)
Control of tuberculosis in Serbia:
Tuberculosis in the United States
Tuberculosis in the United States
World Tuberculosis Day 2014
This is an archived document.
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
Dr Dawood Quiz questions.
Tuberculosis in the United States
TUBERCULOSIS IN VIRGINIA
World Tuberculosis Day 2015
اهمیت سل در چیست؟ حدود یک سوم جمعیت جهان(2 میلیارد نفر)با میکروب سل آلوده شده اند سالانه 9 میلیون نفر به سل فعال مبتلا می شوند هر ساله 1/5 تا 2 میلیون.
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Tuberculosis situation in the EU/EEA, 2016
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
World Tuberculosis Day 2014
Multidrug-resistant tuberculosis and migration to Europe
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X
Success and failure in TB surveillance in Hungary
Timeline of development of key elements of the Cambodian MDR-TB treatment programme. *GLC1 application for patients enrolled in the CAMbodian Early vs.
Goal Objectives Expected Outcomes
Tuberculosis in Japan Annual Report Tuberculosis Surveillance
EXERCISE 11: Computing and Analyzing Program Indicators
Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview
Communicable Disease Surveillance Centre, London
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
5th edition NTP MANUAL OF PROCEDURES Case Finding
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Tuberculosis situation in the EU/EEA, 2017
Preventing recurrent TB in high HIV-prevalent areas
Presentation transcript:

TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016

Fig.1 TB case notifications and rates, 2000-2015

Fig 2. Number of TB cases by selected age groups, 2000-2015

Map 1. TB notification rate by prefectures in Japan, 2015

Fig 3. Proportions of pulmonary and extra-pulmonary diseases by age groups, 2015 PTB bac+: bacteriologically confirmed pulmonary tuberculosis, PTB clin: clinically confirmed pulmonary tuberculosis, ExPTB: extra-pulmonary tuberculosis

Fig 4. Foreign-born TB cases, 2007-2015

Fig 5. Foreign-born TB cases by age groups, 2007-2015

Fig 6. Foreign-born TB cases by selected countries of birth, 2007-2015

Fig 7. Newly notified cases by HIV test results, 2008-2015

Fig 8. Newly notified cases by DM status, 2008-2015 DM: diabetes mellitus

Fig 9. Number of culture confirmed PTB cases and of those whose DST results were known, 2007-2015 PTB : pulmonary tuberculosis, DST: drug susceptibility test

Fig 10. Drug susceptibility test results, 2007-2015 MDR: multi-drug resistance, INH res: isoniazid resistant, RFP res: rifampicin resistant

Fig 11. Proportion of those with delay among pulmonary cases, by age groups, 2015 Patient delay: time between onset of symptoms and initial doctor visit being longer than 2 months, Doctor delay: time between initial doctor visit and diagnosis being longer than 1 month Total delay: time between onset of symptoms and TB diagnosis being longer than 3 months

Fig 12. Proportion of those with delay among sputum smear positive pulmonary cases, by age groups, 2015 Patient delay: time between onset of symptoms and initial doctor visit being longer than 2 months, Doctor delay: time between initial doctor visit and diagnosis being longer than 1 month Total delay: time between onset of symptoms and TB diagnosis being longer than 3 months

Fig 13. Proportion of those with delay among extra-pulmonary cases, by age groups, 2015 Patient delay: time between onset of symptoms and initial doctor visit being longer than 2 months, Doctor delay: time between initial doctor visit and diagnosis being longer than 1 month Total delay: time between onset of symptoms and TB diagnosis being longer than 3 months

Fig 14. Treatment outcome of new sputum smear positive cases by age groups (2014 cohort)

Fig 15. Treatment outcome of new sputum smear positive pulmonary cases aged 49 and below, 2007-2014